A

Anthem Inc
LSE:0HG8

Watchlist Manager
Anthem Inc
LSE:0HG8
Watchlist
Price: 412.25 USD -1.18% Market Closed
Market Cap: 106.6B USD
Have any thoughts about
Anthem Inc?
Write Note

Intrinsic Value

The intrinsic value of one 0HG8 stock under the Base Case scenario is 684.7 USD. Compared to the current market price of 412.25 USD, Anthem Inc is Undervalued by 40%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

0HG8 Intrinsic Value
684.7 USD
Undervaluation 40%
Intrinsic Value
Price
A
Worst Case
Base Case
Best Case

Valuation Backtest
Anthem Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for 0HG8 cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about 0HG8?
Bearish
Neutral
Bullish

Fundamental Analysis

Risks & Rewards

 

 

 

 

View All Risks & Rewards
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Notes
AI Assistant
AI Assistant
Ask me anything about Anthem Inc

Provide an overview of the primary business activities
of Anthem Inc.

What unique competitive advantages
does Anthem Inc hold over its rivals?

What risks and challenges
does Anthem Inc face in the near future?

Summarize the latest earnings call
of Anthem Inc.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Anthem Inc.

Provide P/S
for Anthem Inc.

Provide P/E
for Anthem Inc.

Provide P/B
for Anthem Inc.

Show me price targets
for Anthem Inc made by professional analysts.

What are the Revenue projections
for Anthem Inc?

How accurate were the past Revenue estimates
for Anthem Inc?

What are the Net Income projections
for Anthem Inc?

How accurate were the past Net Income estimates
for Anthem Inc?

What are the EPS projections
for Anthem Inc?

How accurate were the past EPS estimates
for Anthem Inc?

What are the EBIT projections
for Anthem Inc?

How accurate were the past EBIT estimates
for Anthem Inc?

Compare the revenue forecasts
for Anthem Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Anthem Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Anthem Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Anthem Inc compared to its peers.

Compare the P/E ratios
of Anthem Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Anthem Inc with its peers.

Analyze the financial leverage
of Anthem Inc compared to its main competitors.

Show all profitability ratios
for Anthem Inc.

Provide ROE
for Anthem Inc.

Provide ROA
for Anthem Inc.

Provide Net Margin
for Anthem Inc.

Show all solvency ratios
for Anthem Inc.

What is the historical Revenue growth
over the last 5 years for Anthem Inc?

What is the historical Net Income growth
over the last 5 years for Anthem Inc?

What is the current Free Cash Flow
of Anthem Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Anthem Inc.

Business Breakdown

Anthem Inc., one of the largest health benefits companies in the United States, has transitioned from a regional insurer to a formidable national player in the healthcare sector. At its core, Anthem is dedicated to improving health outcomes by offering a range of insurance products and related services, including medical, dental, and vision plans. More than just a health insurance provider, Anthem leverages advanced technology and data analytics to create tailored solutions that address individual healthcare needs, driving both cost efficiency and improved experience for its members. With a robust presence in the individual, employer, and government market segments, the company has demonstra...

Read More
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Anthem Inc

Cash & Short-Term Investments 7.9B
Insurance Receivable 18.4B
PP&E 4.5B
Long-Term Investments 40.4B
Other Assets 45.4B
Insurance Policy Liabilities 15.3B
Short Term Debt 360m
Long Term Debt 24.7B
Other Liabilities 32.4B
Earnings Calls

In the third quarter, Elevance Health reported adjusted diluted earnings per share of $8.37, below expectations due to higher medical costs in Medicaid. The full-year EPS outlook has been revised down to approximately $33. Significant challenges in the Medicaid sector persist, driven by outdated rates not aligned with the current acuity levels of members. However, the company expects robust revenue growth in 2024 and long-term sustainability, with projected revenue growth in the high single-digit percentage range moving forward. Carelon is expected to enhance operational efficiency and scale, generating substantial contributions to the company's growth strategy.

What is Earnings Call?

Wall St
Price Targets

0HG8 Price Targets Summary
Anthem Inc

Wall Street analysts forecast 0HG8 stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for 0HG8 is 566.25 USD with a low forecast of 472.27 USD and a high forecast of 702.14 USD.

Lowest
Price Target
472.27 USD
15% Upside
Average
Price Target
566.25 USD
37% Upside
Highest
Price Target
702.14 USD
70% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for 0HG8?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for 0HG8 is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest

Profile

Anthem Inc

Country

United States of America

Industry

Health Care

Market Cap

106.6B USD

Dividend Yield

1.55%

Description

Anthem, Inc. provides life, hospital and medical insurance plans. The company is headquartered in Indianapolis, Indiana and currently employs 98,200 full-time employees. The company went IPO on 2001-10-30. The firm operates through four segments: Commercial & Specialty Business, Government Business, IngenioRx and Other. The company offers a spectrum of network-based managed care plans to individual, group, Medicaid, and Medicare markets. Its managed care plans include preferred provider organizations; health maintenance organizations; point-of-service plans; traditional indemnity plans and other hybrid plans, including consumer-driven health plans; and hospital only and limited benefit products. The company also provides an array of managed care services to fee-based customers, including claims processing, stop loss insurance, provider network access, medical management, care management and wellness programs, actuarial services and other administrative services. The company provides an array of specialty services including pharmacy management services and dental, vision, life, disability and supplemental health insurance benefits, as well as integrated health services.

Contact

INDIANA
Indianapolis
220 Virginia Avenue
+18003311476.0
www.antheminc.com

IPO

2001-10-30

Employees

98 200

Officers

President, CEO & Director
Ms. Gail Koziara Boudreaux
Executive VP & CFO
Mr. Mark Bradley Kaye
Executive VP and Chief Legal & Administrative Officer
Mr. Blair Williams Todt
Executive VP and President of Carelon & CarelonRx
Mr. Peter David Haytaian Esq.
Executive VP & President of Government Health Benefits
Ms. Felicia Farr Norwood
SVP, Treasurer & Chief Investment Officer
Mr. Scott Wayne Anglin
Show More
Senior VP, Controller & Chief Accounting Officer
Mr. Ronald William Penczek
Vice President of Investor Relations
Mr. Stephen Vartan Tanal C.F.A.
Senior Vice President of Public Affairs
Ms. Julie Goon
Chief Strategy Officer & Interim Chief Marketing Officer
Mr. Kyle Weber
Show Less

See Also

Discover More
What is the Intrinsic Value of one 0HG8 stock?

The intrinsic value of one 0HG8 stock under the Base Case scenario is 684.7 USD.

Is 0HG8 stock undervalued or overvalued?

Compared to the current market price of 412.25 USD, Anthem Inc is Undervalued by 40%.

Back to Top